Vanguard Group Inc Nevro Corp Transaction History

Vanguard Group Inc

  • $5.37 Trillion
  • Q1 2025

A detailed history of Vanguard Group Inc transactions in Nevro Corp stock. As of the latest transaction made, Vanguard Group Inc holds 2,070,027 shares of NVRO stock, worth $12.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,070,027
Previous 2,062,193 0.38%
Holding current value
$12.1 Million
Previous $7.67 Million 57.58%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 09, 2025
BUY
$3.29 - $5.85 $25,773 - $45,828
7,834 Added 0.38%
2,070,027 $12.1 Million
Q4 2024

Feb 11, 2025
SELL
$3.59 - $5.78 $121,144 - $195,046
-33,745 Reduced 1.61%
2,062,193 $7.67 Million
Q3 2024

Nov 13, 2024
SELL
$4.71 - $10.1 $1.24 Million - $2.67 Million
-264,250 Reduced 11.2%
2,095,938 $11.7 Million
Q2 2024

Aug 13, 2024
SELL
$7.96 - $13.59 $6.48 Million - $11.1 Million
-813,715 Reduced 25.64%
2,360,188 $19.9 Million
Q1 2024

May 10, 2024
SELL
$13.56 - $20.78 $12.1 Million - $18.6 Million
-893,368 Reduced 21.96%
3,173,903 $45.8 Million
Q4 2023

Feb 14, 2024
SELL
$14.18 - $22.31 $2.33 Million - $3.67 Million
-164,634 Reduced 3.89%
4,067,271 $87.5 Million
Q3 2023

Nov 14, 2023
SELL
$18.22 - $25.85 $193,441 - $274,449
-10,617 Reduced 0.25%
4,231,905 $81.3 Million
Q2 2023

Aug 14, 2023
SELL
$22.62 - $39.32 $2.78 Million - $4.83 Million
-122,865 Reduced 2.81%
4,242,522 $108 Million
Q1 2023

May 15, 2023
BUY
$30.17 - $41.11 $7.85 Million - $10.7 Million
260,037 Added 6.33%
4,365,387 $158 Million
Q4 2022

Feb 10, 2023
BUY
$36.43 - $49.4 $17.6 Million - $23.9 Million
484,265 Added 13.37%
4,105,350 $163 Million
Q3 2022

Nov 14, 2022
BUY
$40.66 - $53.03 $2.45 Million - $3.2 Million
60,289 Added 1.69%
3,621,085 $169 Million
Q2 2022

Aug 12, 2022
BUY
$40.85 - $77.67 $12.6 Million - $24 Million
308,385 Added 9.48%
3,560,796 $156 Million
Q1 2022

May 13, 2022
BUY
$59.95 - $92.06 $4.03 Million - $6.19 Million
67,233 Added 2.11%
3,252,411 $235 Million
Q4 2021

Feb 14, 2022
SELL
$81.07 - $121.29 $4.38 Million - $6.55 Million
-54,036 Reduced 1.67%
3,185,178 $258 Million
Q3 2021

Nov 12, 2021
SELL
$101.99 - $166.36 $11.2 Million - $18.3 Million
-109,897 Reduced 3.28%
3,239,214 $377 Million
Q2 2021

Aug 13, 2021
BUY
$141.6 - $179.06 $474 Million - $600 Million
3,349,111 New
3,349,111 $555 Million

Others Institutions Holding NVRO

# of Institutions
145
Shares Held
35.6M
Call Options Held
208K
Put Options Held
421K
View Full List

About NEVRO CORP

NVRO Quotes by TradingView
  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $207M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email